Titre:
  • Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.
Auteur:Noens, Lucien; van Lierde, Marie-Anne; De Bock, R; Verhoef, G; Zachée, Pierre; Berneman, Zwi Nisan; Martiat, Philippe; Mineur, Philippe; Van Eygen, Koen; MacDonald, Karen; De Geest, Sabina; Albrecht, Tara; Abraham, Ivo
Informations sur la publication:Blood, 113, 22, page (5401-5411)
Statut de publication:Publié, 2009-05
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Case-Control Studies
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- epidemiology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- psychology
Male
Middle Aged
Patient Compliance -- statistics & numerical data
Piperazines -- adverse effects
Piperazines -- therapeutic use
Prevalence
Pyrimidines -- adverse effects
Pyrimidines -- therapeutic use
Retrospective Studies
Risk Factors
Treatment Outcome
Young Adult
Note générale:Evaluation Studies
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0006-4971
info:doi/10.1182/blood-2008-12-196543
info:pii/blood-2008-12-196543
info:scp/67049087117
info:pmid/19349618